StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
300175.SZ$6.41+0.00%
Fair $6.41+0.0%

300175.SZ

Lontrue Co., Ltd.

Consumer Defensive / Farm ProductsShenzhen

$6.41

+0.00 (+0.00%)

Fairly Valued+0.0%Fair Value $6.41Fund rank 28/100 · Data gapFallback financials|
SA 31/D
F-Score: 3/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 19%

FCF escenarios

weak_data · normalized FCF $-38.6M · quality 50.3/100

Data gap 28/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 17/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

31/100

D

Piotroski

3/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is -3.0%, below the 5% threshold
Thesis & Journal · 300175.SZLocal privado en este navegador · Lontrue Co., Ltd.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$3.0B

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

-3.0%

↓

Gross Margin

8.2%

↓

Debt/Equity

0.07

↓
52-Week Range$6
$5$7

TradingView lightweight chart

300175.SZ price, volumen y niveles de valoración

Último $6.410Periodo +31.7%
Fair value: $6.410

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+10.6%

FCF CAGR

—

FCF margin

-21.9%

FCF / Net income

4.26x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $291.7M · net income $-15.0M · FCF $-63.8M

2022-FY → 2025-FY

Gross margin

8.2%-6.4% pts

Operating margin

-2.9%-6.9% pts

Net margin

-5.1%+7.7% pts

FCF margin

-21.9%-40.0% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$291.7M$291.7M$245.4M$220.2M$215.6M
Net Income$-15.0M$-15.0M$-36.4M$-53.6M$-27.8M
EBITDA$-3.7M$-3.7M$-11.5M$-44.2M$-6.3M
EPS-0.03-0.03-0.08-0.11-0.06
Gross Margin8.2%8.2%11.2%16.7%14.7%
Operating Margin-2.9%-2.9%-5.6%6.4%3.9%
Net Margin-5.1%-5.1%-14.9%-24.3%-12.9%
Balance Sheet
Debt/Equity0.070.070.030.120.07
Current Ratio5.765.76———
Cash Flow
Free Cash Flow$-63.8M$-63.8M$-38.6M$-8.3M$39.0M
Returns
ROE-3.0%-3.0%-7.0%-10.7%-5.0%
Valuation
P/B5.995.994.695.713.21
Growth & Yield
Revenue Growth18.9%18.9%11.4%2.1%—
EPS Growth58.9%58.9%29.6%-83.3%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +22.6%

Total return

+22.6%

Start / end P/E

n/dx → n/dx

EPS bridge

-0.08 → -0.03

Residual

+22.6%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term+22.6%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.